BTX-306

N/A

Report date: 2023/01/08 22:49:50
NME

Base Information

Drug NameBTX-306
Drug Alias NameBTX-306
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degraders
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3A
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiotheryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiotheryx Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A